Suchergebnisse - "Labar, Boris"

1

Terminal deoxynucleotidyl transferase negative T-cell lymphoblastic lymphoma in aleukemic patient

von: Brčić, Iva

2008, in: International journal of hematology

Wird geladen...
2

Splenectomy? No, thank you!

von: Huić, Dražen

2004, in: European journal of nuclear medicine and molecular imaging

Wird geladen...
3

LightCycler SeptiFast assay as a tool for the rapid diagnosis of sepsis in patients receiving antimicrobial therapy

von: Vince, Adriana

2008, in: Critical care

Wird geladen...
4

Analysis of Clonality in T-Lymphoproliferative Diseases by Multiplex PCR

von: Zadro, Renata

2005, Walter de Gruyter

Wird geladen...
5

Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients with Diffuse Large B-cell Lymphoma Treated with Rituximab and CHOP

von: Mitrović, Zdravko

2010, in: Pathology & oncology research

Wird geladen...
6

Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab

von: Ilić, Ivana

2009, in: International journal of hematology

Wird geladen...
7

The effect of HLA allele and haplotype polymorphisms on donor matching in hematopoietic stem cell transplantation – Croatian experience

von: Grubic, Zorana

2016, in: Towards a Dynamic Understanding of Cadherin-Based Mechanobiology

Wird geladen...
8

High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin’s lymphoma

von: Aurer, Igor

2016, in: Annals of hematology

Wird geladen...
9

Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years

von: Giebel, Sebastian

2009, in: Annals of hematology

Wird geladen...
10

Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies

von: Oosterveld, Margriet

2014, in: Annals of hematology

Wird geladen...
11

Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG)

von: Becker, Heiko

2015, in: Annals of hematology

Wird geladen...
12

Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group

von: Lübbert, Michael

2015, in: Annals of hematology

Wird geladen...
13

Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial

von: Aslanyan, Mariam G.

2014, in: Annals of hematology

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!